US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuphoria Therapeutics Inc

7.43

-0.3200-4.13%

Volume:22.21K

Turnover:168.29K

Market Cap:16.80M

PE:4.37K

High:7.87

Open:7.63

Low:7.40

Close:7.75

52wk High:12.55

52wk Low:2.90

Shares:2.26M

Float Shares:1.23M

Volume Ratio:1.29

T/O Rate:1.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0017

EPS(LYR):-0.0086

ROE:25.45%

ROA:-1.01%

PB:0.65

PE(LYR):-862.15

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Neuphoria Therapeutics Receives Nasdaq Notice for Failing to Hold Timely Annual Shareholder Meeting

Neuphoria Therapeutics Q1 EPS $6.55 Up From $(2.83) YoY, Sales $15.00M

Neuphoria Provides First Quarter 2025 Business Updates

THOMSON REUTERS

BRIEF-Neuphoria Therapeutics Says Cash Runway Extends Into Q3 2026 - SEC Filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NEUP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEUP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","market":"US","secType":"STK","nameCN":"Neuphoria Therapeutics Inc","latestPrice":7.43,"timestamp":1754683200000,"preClose":7.75,"halted":0,"volume":22213,"delay":0,"floatShares":1227800,"shares":2261600,"eps":0.001699,"marketStatus":"Market Closed","change":-0.32,"latestTime":"08-08 16:00:00 EDT","open":7.63,"high":7.87,"low":7.4,"amount":168293.3155,"amplitude":0.060645,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.001699,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.75,"volumeRatio":1.290883106417928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","floatShares":1227800,"roa":"-1.01%","roe":"25.45%","lyrEps":-0.008618,"volumeRatio":1.290883106417928,"shares":2261600,"dividePrice":0,"high":7.87,"amplitude":0.060645,"preClose":7.75,"low":7.4,"week52Low":2.9,"pbRate":"0.65","psRate":"1.07","week52High":12.55,"institutionHeld":0.0927,"latestPrice":7.43,"eps":0.001699,"divideRate":0,"volume":22213,"delay":0,"ttmEps":0.001699,"open":7.63,"prevYearClose":3.43,"prevWeekClose":8.05,"prevMonthClose":8.11,"prevQuarterClose":7.1,"fiveDayClose":8.05,"twentyDayClose":7.69,"sixtyDayClose":4.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEUP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-12-24","symbol":"NEUP","defaultRemindTime":1735050600000,"type":"split","dateTimestamp":1735016400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEUP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEUP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1695960000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NEUP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NEUP","date":"2025-08-08","current":2.500379,"percent":0.934641,"low":-2152.911097,"twenty":-1.107461,"median":-0.765954,"eighty":2.294542,"high":2.803651,"avg":-52.713469,"sd":273.872698,"marketCap":14569705},"quantilePoints":[{"date":"2024-12-27","current":-1445.015744,"twenty":-2011.332026,"median":-1798.963421,"eighty":-1586.594815,"marketCap":15641406744},{"date":"2025-01-03","current":-951.437333,"twenty":-1445.015744,"median":-1245.311321,"eighty":-1113.798652,"marketCap":10298723991},{"date":"2025-01-10","current":-0.484092,"twenty":-1335.908938,"median":-1032.617992,"eighty":-0.531583,"marketCap":5240001},{"date":"2025-01-17","current":-0.452507,"twenty":-1207.318772,"median":-0.536694,"eighty":-0.48107,"marketCap":4898109},{"date":"2025-01-24","current":-0.524667,"twenty":-1141.075354,"median":-0.511137,"eighty":-0.48107,"marketCap":5679203},{"date":"2025-01-31","current":-0.81331,"twenty":-1016.381861,"median":-0.554735,"eighty":-0.482883,"marketCap":8803579},{"date":"2025-02-07","current":-0.757686,"twenty":-381.062919,"median":-0.702062,"eighty":-0.484985,"marketCap":8201486},{"date":"2025-02-14","current":-0.691539,"twenty":-0.803388,"median":-0.699056,"eighty":-0.486483,"marketCap":7485483},{"date":"2025-02-21","current":-1.080318,"twenty":-1.103422,"median":-0.706573,"eighty":-0.495533,"marketCap":8872986},{"date":"2025-02-28","current":-1.110267,"twenty":-1.105989,"median":-0.757686,"eighty":-0.509378,"marketCap":9118970},{"date":"2025-03-07","current":-1.180862,"twenty":-1.111551,"median":-0.770464,"eighty":-0.516549,"marketCap":9698789},{"date":"2025-03-14","current":-1.035394,"twenty":-1.111551,"median":-0.796773,"eighty":-0.529478,"marketCap":8504010},{"date":"2025-03-21","current":-1.108128,"twenty":-1.110267,"median":-1.022558,"eighty":-0.551126,"marketCap":9101399},{"date":"2025-03-28","current":-1.240761,"twenty":-1.1415,"median":-1.048229,"eighty":-0.607653,"marketCap":10190756},{"date":"2025-04-04","current":-1.210812,"twenty":-1.180862,"median":-1.055716,"eighty":-0.664779,"marketCap":9944772},{"date":"2025-04-11","current":-1.048229,"twenty":-1.179151,"median":-1.052508,"eighty":-0.679813,"marketCap":8609432},{"date":"2025-04-17","current":-1.093153,"twenty":-1.172305,"median":-1.056786,"eighty":-0.692441,"marketCap":8978407},{"date":"2025-04-25","current":-1.110267,"twenty":-1.154335,"median":-1.064274,"eighty":-0.697252,"marketCap":9118970},{"date":"2025-05-02","current":-1.069622,"twenty":-1.152624,"median":-1.071761,"eighty":-0.702663,"marketCap":8785135},{"date":"2025-05-09","current":-1.056786,"twenty":-1.146207,"median":-1.070692,"eighty":-0.70567,"marketCap":8679713},{"date":"2025-05-16","current":-1.014001,"twenty":-1.12567,"median":-1.069622,"eighty":-0.714089,"marketCap":8328307},{"date":"2025-05-23","current":1.878545,"twenty":-1.12567,"median":-1.066199,"eighty":-0.70567,"marketCap":10946278},{"date":"2025-05-30","current":2.090639,"twenty":-1.118824,"median":-1.058925,"eighty":-0.691539,"marketCap":12182153},{"date":"2025-06-06","current":2.306801,"twenty":-1.112407,"median":-1.056786,"eighty":-0.536694,"marketCap":13441728},{"date":"2025-06-13","current":2.303575,"twenty":-1.112407,"median":-1.053577,"eighty":-0.487084,"marketCap":13422928},{"date":"2025-06-20","current":2.135807,"twenty":-1.112407,"median":-1.052016,"eighty":-0.48107,"marketCap":12445348},{"date":"2025-06-27","current":2.193881,"twenty":-1.110695,"median":-1.048229,"eighty":-0.028511,"marketCap":12783741},{"date":"2025-07-03","current":2.300349,"twenty":-1.110267,"median":-1.04609,"eighty":1.971267,"marketCap":13404129},{"date":"2025-07-11","current":2.451984,"twenty":-1.110267,"median":-1.029511,"eighty":2.139033,"marketCap":14287711},{"date":"2025-07-18","current":2.416495,"twenty":-1.110267,"median":-1.009723,"eighty":2.183557,"marketCap":14080915},{"date":"2025-07-25","current":2.710088,"twenty":-1.108984,"median":-0.902959,"eighty":2.199559,"marketCap":15791680},{"date":"2025-08-01","current":2.616525,"twenty":-1.108128,"median":-0.783243,"eighty":2.258407,"marketCap":15246491},{"date":"2025-08-08","current":2.500379,"twenty":-1.107461,"median":-0.765954,"eighty":2.294542,"marketCap":14569705}],"updateTime":1754732825560},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NEUP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552490144","title":"Neuphoria Therapeutics Receives Nasdaq Notice for Failing to Hold Timely Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2552490144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552490144?lang=en_us&edition=fundamental","pubTime":"2025-07-19 05:01","pubTimestamp":1752872464,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics Inc. has announced that it received a deficiency notification from Nasdaq, indicating non-compliance with Nasdaq Listing Rule 5620. The company failed to hold an annual meeting of stockholders within 12 months of the fiscal year ending June 30, 2024. Neuphoria has until September 1, 2025, to submit a compliance plan, and if accepted, Nasdaq may grant an extension until December 29, 2025. The company plans to hold its 2025 annual meeting in November to address the issue and maintain its listing status. The notice currently has no immediate impact on its Nasdaq listing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuphoria Therapeutics Inc. published the original content used to generate this news brief via EDGA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL8CYzzS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"2537462346","title":"Neuphoria Therapeutics Q1 EPS $6.55 Up From $(2.83) YoY, Sales $15.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2537462346","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537462346?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:27","pubTimestamp":1747772835,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics (NASDAQ:NEUP) reported quarterly earnings of $6.55 per share. This is a 331.45 percent increase over losses of $(2.83) per share from the same period last year.  The company reported $15.00 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45530037/neuphoria-therapeutics-q1-eps-6-55-up-from-2-83-yoy-sales-15-00m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","NEUP"],"gpt_icon":0},{"id":"2537239746","title":"Neuphoria Provides First Quarter 2025 Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2537239746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537239746?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:22","pubTimestamp":1747772560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nTUA2NFQDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NEUP","BK4139"],"gpt_icon":0},{"id":"2537623927","title":"BRIEF-Neuphoria Therapeutics Says Cash Runway Extends Into Q3 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537623927","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537623927?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:21","pubTimestamp":1747772488,"startTime":"0","endTime":"0","summary":"BRIEF-Neuphoria Therapeutics Says Cash Runway Extends Into Q3 2026 - SEC FilingMay 20  - Neuphoria Therapeutics Inc NEUP.O:NEUPHORIA THERAPEUTICS INC - CASH RUNWAY EXTENDS INTO Q3 2026 - SEC FILINGNEUPHORIA THERAPEUTICS INC - AFFIRM-1 PHASE 3 TRIAL OF BNC-210 TOPLINE READOUT EXPECTED Q3 2025 - SEC FILINGSource text: [ID:n0001213900-25-045970]Further company coverage: NEUP.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RS1VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEUP","BK4139"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NEUP\",params:#limit:6,delay:false,,,undefined,":[]}}